The Indian and Global Vaccine Industry Meets in Hyderabad, India
Recognizing that India plays a crucial role in supplying the world with vaccines, IMAPAC is organizing the 4th Annual Vaccine World Summit India 2014 on 4 - 6 March in Hyderabad, India.
- (1888PressRelease) February 10, 2014 - The Indian economy is among the fastest growing economies in the world, with research showing that the industry will see more than 25 products in the pipeline of Indian vaccine manufacturers, and that the market is expecting growth of 10%-13% for the next ten years.
India is the major supplier of basic Expanded Programme on Immunization vaccine to the United Nations Childres's Fund (UNICEF). Dr Suresh Jadhav, Executive Director, Serum Institute of India showed the importance India as a global vaccine supplier, when he said, "Around 75-to-80% of vaccines developed and procured by UN agencies are from the developing world and almost 80% of these are from India".
The Indian vaccine manufacturers are more involved in the global market than ever. More international collaborations can be seen and the Indian vaccine players are also stepping up their game by acquiring foreign partners around the world. With such trends growing strong, IMAPAC is proud to provide a platform to connect key stakeholders, to facilitate learning, as well as sharing of experiences and knowledge at the 4th Annual Vaccine World Summit in India.
This conference features a distinguished panel more than 35 speakers and advisers; each of them playing important roles in their organizations. Key speaking and advising faculty includes:
Dr. Ted Bianco, Director, Technology Transfers Wellcome Trust, United Kingdom
Dr. Krishna M. Ella, Founder, Bharat Biotech, India
Dr. Harish Iyer, CEO, Shantha Biotechnics, India
Ms. Mahima Datla, Managing Director, Biological E Pvt Ltd, India
Dr. S. D. Ravetkar, Executive Director, Serum Institute of India, India
Dr. T. S. Rao, Adviser, DBT, Government of India
Dr. Ravi Dhar, Senior Consultant, BIRAC, DBT, Government of India
Dr. Kutub Mahamood, Scientific Director, Polio Vaccine Development & Scale Up, PATH, USA
Dr. Suniti Soloman, Founder- Director, YRG Care, India
Dr. Sonali Kochchar, Clinical Research & Drug Development Specialist, PATH, India
Mr. Raj Mehta, Head, South East Asia Cluster, Novartis Vaccines and Diagnostics, Singapore
Dr. Josemund Menezes, Regional Director Clinical Development Asia Pacific, Sanofi Pasteur, India
Dr. Priya Pereira, Senior Medical Advisor - Pediatric Vaccines, Glaxo Smith Kline Vaccines, India
Dr. Ingmar Hoerr, Founder & CEO, Curevac, Germany
Prof. Nikolai Petrovsky, Chairman, Vaxine, Australia
Dr. Bernd Eisele, CEO, Vakzine Projekt Management, Germany
Prof. V. S. Chauhan, Group Leader and part of governing body, ICGEB and MVDP, India
Dr. K. Zaman, Head, Vaccine Surveillance Research Group; Scientist and Epidemiologist ICCDR, Bangladesh
Mr. K. V. Balasubramanium, Managing Director, Indian Immmunologicals, India
Dr. Ramesh Mathur, Senior Vice President, Research and Development, Biological E Pvt Ltd, India
Dr. Mandeep Singh Dhingra, Chief Clinical Officer Shantha Biotechnics Limited, India
Mr. Ricardo Pιrez Valerino, Director of International Relations, Finlay Institute, Cuba
Ms. Meredith Shirey Chief Vaccine Center, UNICEF Supply Division, Denmark
These key opinion leaders will share their thoughts and discuss key concerns revolving Regulations, New Technologies, Partnerships and Clinical Trials.
The 4th Annual Vaccine World Summit is also proud to be supported by international organizations such as Wellcome Trust, Bio Deutschland, the Embassy of Netherlands and more.
For more information on the upcoming event, please contact Jen Cheng
at the following information:
Jen.cheng ( @ ) imapac dot com
+65 6493 1871
###
space
space
Satisfied Users & 
Approved Press Releases
Print
Email
Report Spam